[Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?] [0.03%]
用欣麦拉嘉退治疗心房颤动的抗凝法：可以取代warfarin吗？
Izzet Tandoğan
Izzet Tandoğan
[Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?] [0.03%]
房颤的抗凝治疗：Iximelagatran能否取代华法林？
F Suna Kiraç
F Suna Kiraç
[Importance of metabolic syndrome definitions in prediction of cardiometabolic risk/ prospective validation in identical Turkish cohort of two metabolic syndrome definitions for predicting cardiometabolic risk and selection of most appropriate definition] [0.03%]
[代谢综合征定义在预测心血管代偿风险中的作用/前瞻性验证同一土耳其队列中两种代谢综合征定义的预测心血管元代偿风险的选择最适当的定义]
Fulden Saraç
Fulden Saraç
Bahri Akdeniz
Bahri Akdeniz
Left pericardial agenesis in a patient with sinus venosus type atrial septal defect [0.03%]
左心包缺如合并静脉窦型房间隔缺损患者
Zeynep Eyileten,Mehmet Arikbuka,Levent Yazicioğlu et al.
Zeynep Eyileten et al.
Giant pulmonary artery aneurysm due to undiagnosed atrial septal defect associated with pulmonary hypertension [0.03%]
未诊断的房间隔缺损伴肺动脉高压引起的巨大肺动脉瘤
Zeynep Tartan,Neşe Cam,Nihat Ozer et al.
Zeynep Tartan et al.
Mehmet Ozkökeli,Ilyas Kayacioğlu,Yavuz Sensöz et al.
Mehmet Ozkökeli et al.